Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis-Reference-Cited by-同舟云学术

Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis

Published:2016-04-10 Issue: Volume:22 Page:1192-1209
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Nicoară Simona D.¹,Ștefănuţ Anne C.²,Nascutzy Constanta³,Zaharie Gabriela C.⁴,Toader Laura E.¹,Drugan Tudor C.⁵

Affiliation:

1. Department of Ophthalmology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

2. Department of Ophthalmology, Emergency County Hospital, Cluj-Napoca, Romania

3. Department of Ophthalmology, Institute for Mother and Child Care, Bucharest, Romania

4. Department of Neonatology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

5. Department of Medical Informatics and Biostatistics, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03

2. The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis;Italian Journal of Pediatrics;2023-10-09

3. Reactivation of retinopathy of prematurity after intravitreal bevacizumab monotherapy in aggressive posterior retinopathy of prematurity;Journal of Clinical Ophthalmology and Research;2023

4. A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept, and Laser for Retinopathy of Prematurity;Ophthalmology;2022-12

5. Comparison of adverse events between intravitreal anti-VEGF and laser photocoagulation for treatment-requiring retinopathy of prematurity: a systematic review;International Ophthalmology;2022-10-10